ON
← Back to feed
Innovative ‘sponge on a string’ cancer test recommended for NHS roll-out
United Kingdom🩺 HealthCenter

Innovative ‘sponge on a string’ cancer test recommended for NHS roll-out

The National Institute for Health and Care Excellence (Nice) has issued draft guidance recommending the adoption of two non-invasive 'sponge on a string' tests, Cytosponge and EndoSign, within the National Health Service. These procedures allow patients at high risk of oesophageal cancer to undergo screening in general practices or community centers without requiring sedation or traditional endoscopy. The method involves swallowing a capsule that releases a sponge to collect cell samples from the esophagus over a period of roughly seven minutes. Nice officials stated that this approach is preferred by patients and helps identify Barrett’s oesophagus earlier, potentially improving outcomes for a disease that is frequently detected at advanced stages. The recommendation aims to optimize NHS resources by reserving invasive endoscopies for cases where they are strictly necessary.

4 reports

The Independent logoThe IndependentIndependentCenter
Innovative ‘sponge on a string’ cancer test recommended for NHS roll-out

The National Institute for Health and Care Excellence (Nice) has issued draft guidance recommending the adoption of two non-invasive 'sponge on a string' tests, Cytosponge and EndoSign, within the National Health Service. These procedures allow patients at high risk of oesophageal cancer to undergo screening in general practices or community centers without requiring sedation or traditional endoscopy. The method involves swallowing a capsule that releases a sponge to collect cell samples from the esophagus over a period of roughly seven minutes. Nice officials stated that this approach is preferred by patients and helps identify Barrett’s oesophagus earlier, potentially improving outcomes for a disease that is frequently detected at advanced stages. The recommendation aims to optimize NHS resources by reserving invasive endoscopies for cases where they are strictly necessary.

Bias read (Center): The article relies exclusively on official medical recommendations and neutral technical descriptions, presenting the health policy update without partisan commentary or ideological framing.

The Independent logoThe IndependentIndependentCenter
‘Sponge on a string’ cancer test recommended for NHS roll-out

The NHS in England is set to introduce a new 'sponge on a string' test for detecting Barrett’s oesophagus, a precursor to oesophageal cancer. This non-invasive method allows patients to swallow a capsule containing a sponge, which is retrieved via a string after collecting cell samples from the oesophagus. The National Institute for Health and Care Excellence (NICE) has endorsed this approach alongside another test called EndoSign, citing patient preference over traditional endoscopies. Oesophageal cancer is often diagnosed at a late stage, making early detection crucial. The test aims to improve accessibility and reduce strain on endoscopy resources by offering a quicker alternative for high-risk individuals.

Bias read (Center): The article presents factual information about a medical innovation without overtly favoring any political stance or ideology.

Daily Mirror logoDaily MirrorIndependentCenter
NHS could offer thousands new test that spots oesophageal cancer risk before it develops

Draft guidance from the National Institute for Health and Care Excellence (NICE) recommends the adoption of two capsule sponge tests, Cytosponge and EndoSign, within the NHS to screen for Barrett's oesophagus. This condition, caused by stomach acid damaging the oesophagus, affects approximately 1% to 2% of adults and serves as a precursor to oesophageal cancer. The procedure involves swallowing a capsule that releases a sponge to collect cells for analysis, taking about seven minutes and requiring no sedation. NICE notes that patients generally prefer this method over traditional endoscopy, allowing the NHS to reserve endoscopy resources for more complex cases. With over 9,000 oesophageal cancer diagnoses annually in the UK, early detection aims to improve treatment outcomes.

Bias read (Center): The article presents a straightforward medical update using neutral language and relies exclusively on official quotes from NICE and NHS England regarding a new screening guideline.

BBC News (UK) logoBBC News (UK)State / PublicCenter
Cancer 'sponge' tests could be offered to more people with bad indigestion

A new non-invasive sponge test is being considered for wider use in the UK to detect early signs of esophageal cancer and Barrett's oesophagus in individuals with chronic indigestion. The test involves swallowing a dissolving capsule containing a small sponge, which collects cells from the esophagus lining for analysis. It is seen as a quicker and less intrusive alternative to traditional endoscopies, which are currently in high demand within the NHS. Experts suggest the test could reduce the burden on healthcare systems while allowing for earlier detection of potential issues. However, NICE emphasizes that no test is foolproof, and those receiving negative results should continue long-term monitoring.

Bias read (Center): The article presents medical developments neutrally, citing health experts and NICE guidelines without apparent ideological framing or biased language.

How each side covered it

The same event, grouped by the political lean of the outlets covering it.

How each side covered it

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Covered around the world

The same event as reported in other countries.

Covered around the world

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Claims check

Key factual claims, and how many sources assert vs dispute each.

Claims check

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Keep the news honest.

ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.

Become a Supporter

Related stories